Drug safety assessment
SAFEPATH uses deep learning to identify toxicity mechanisms, predict effects on the human body, and assess them alongside therapeutic effectiveness.
Source: LinkedIn company description · Retrieved October 13, 2026
Ignota Labs applies its proprietary AI model to drug safety issues.
Ignota Labs looks at historically failed clinical trials and abandoned internal projects to identify promising targets. The company focuses on safety problems in preclinical, Phase 1, and Phase 2 trials.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
SAFEPATH uses deep learning to identify toxicity mechanisms, predict effects on the human body, and assess them alongside therapeutic effectiveness.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 3, 2026, September 4, 2026, September 6, 2026, September 10, 2026, September 11, 2026, September 18, 2026, September 21, 2026, September 26, 2026, September 27, 2026, September 28, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.